FKN treatment could maintain microglia in a quiescent state, suggesting its neuroprotective effect via modulation of microglia in rodents with permanent focal cerebral ischemia14 and in rat model of Parkinson's disease.15 The gene discussed is CX3CL1; the disease is Parkinson disease.